Integrating Patient-Reported Outcome Measures into Routine Cancer Care: Cancer Patients' and Clinicians' Perceptions of Acceptability and Value.

INTRODUCTION - Despite growing interest in integrating patient-reported outcome (PRO) measures of symptoms and functional status into routine cancer care, little attention has been paid to patients' and clinicians' perceptions of acceptability and value.

METHODS - A two-phase qualitative study was conducted to develop a web-based PRO screening system with 21 items assessing symptoms (e. g. , nausea) and functional status. Phase 1 involved cognitive interviews with 35 cancer outpatients (n=9 breast chemotherapy, radiation for prostate (n=8) or head and neck cancer (n=10), and n=8 bone marrow transplant [BMT]). In Phase 2, we evaluated the acceptability and perceived value of reviewing a PRO measure during real-time clinical encounters with 39 additional outpatients (n=10 breast, n=9 head and neck, n=10 prostate, n=10 BMT) and 12 clinicians (n=3 breast, n=2 head and neck, n=4 prostate, n=3 BMT). At least 20% of patients were ≥60 years, African American, or ≤ high school.

RESULTS - Patients felt that their PRO summary of symptoms and functional status was helpful in discussing health issues with clinicians (92%), wanted to review their results with clinicians during future visits (82%), and would recommend it to other patients (87%). Clinicians found the PRO summary to be easy to interpret (83%), most helpful for documenting the Review of Symptoms (92%), and would recommend it to future patients (92%). Over 90% of clinicians reported that consultation time did not increase.

CONCLUSION - Both cancer patients and clinicians reported that discussing a PRO summary of symptoms and functional status during an outpatient visit was useful, acceptable, and feasible.

EGEMS (Washington, DC). 2015 Oct 29*** epublish ***

Angela Stover, Debra E Irwin, Ronald C Chen, Bhishamjit S Chera, Deborah K Mayer, Hyman B Muss, Donald L Rosenstein, Thomas C Shea, William A Wood, Jessica C Lyons, Bryce B Reeve

University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , University of North Carolina at Chapel Hill. , Harvard University. , University of North Carolina at Chapel Hill.

PubMed      Full Text Article

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe